Literature DB >> 11269222

The autoimmune lymphoproliferative syndrome. A disorder of human lymphocyte apoptosis.

T A Fleisher1, J M Puck, W Strober, J K Dale, M J Lenardo, R M Siegel, S E Straus, J J Bleesing.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11269222     DOI： 10.1385/criai:20:1:109

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN： 1080-0549            Impact factor:   10.817


× No keyword cloud information.
  21 in total

1.  Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.

Authors:  J Drappa; A K Vaishnaw; K E Sullivan; J L Chu; K B Elkon
Journal:  N Engl J Med       Date:  1996-11-28       Impact factor: 91.245

2.  Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.

Authors:  D A Martin; L Zheng; R M Siegel; B Huang; G H Fisher; J Wang; C E Jackson; J M Puck; J Dale; S E Straus; M E Peter; P H Krammer; S Fesik; M J Lenardo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

3.  Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.

Authors:  C E Jackson; R E Fischer; A P Hsu; S M Anderson; Y Choi; J Wang; J K Dale; T A Fleisher; L A Middelton; M C Sneller; M J Lenardo; S E Straus; J M Puck
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

Review 4.  An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.

Authors:  S E Straus; M Sneller; M J Lenardo; J M Puck; W Strober
Journal:  Ann Intern Med       Date:  1999-04-06       Impact factor: 25.391

5.  Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

Authors:  G H Fisher; F J Rosenberg; S E Straus; J K Dale; L A Middleton; A Y Lin; W Strober; M J Lenardo; J M Puck
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

6.  The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.

Authors:  A J Infante; H A Britton; T DeNapoli; L A Middelton; M J Lenardo; C E Jackson; J Wang; T Fleisher; S E Straus; J M Puck
Journal:  J Pediatr       Date:  1998-11       Impact factor: 4.406

7.  A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

Authors:  M C Sneller; S E Straus; E S Jaffe; J S Jaffe; T A Fleisher; M Stetler-Stevenson; W Strober
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

8.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

9.  The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster.

Authors:  D H Lynch; M L Watson; M R Alderson; P R Baum; R E Miller; T Tough; M Gibson; T Davis-Smith; C A Smith; K Hunter
Journal:  Immunity       Date:  1994-05       Impact factor: 31.745

10.  Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.

Authors:  A Bettinardi; D Brugnoni; E Quiròs-Roldan; A Malagoli; S La Grutta; A Correra; L D Notarangelo
Journal:  Blood       Date:  1997-02-01       Impact factor: 22.113
View more
  3 in total

Review 1.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

2.  Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder.

Authors:  Leonardo Salmena; Razqallah Hakem
Journal:  J Exp Med       Date:  2005-09-12       Impact factor: 14.307

3.  c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.

Authors:  Stephan Mathas; Andreas Lietz; Ioannis Anagnostopoulos; Franziska Hummel; Burkhard Wiesner; Martin Janz; Franziska Jundt; Burkhard Hirsch; Korinna Jöhrens-Leder; Hans-Peter Vornlocher; Kurt Bommert; Harald Stein; Bernd Dörken
Journal:  J Exp Med       Date:  2004-04-12       Impact factor: 14.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.